Pro/con debate: Is etomidate safe in hemodynamically unstable critically ill patients?

Area of Science:

• Critical Care Medicine
• Anesthesiology
• Pharmacology

Background:

• Etomidate is a common induction agent for anesthesia.
• It provides excellent intubating conditions and cardiovascular stability.
• Concerns exist regarding etomidate-induced adrenal insufficiency, particularly after a single dose.

Purpose of the Study:

• To review the pros and cons of using etomidate in hemodynamically unstable critically ill patients.
• To discuss the implications of etomidate's adrenal suppression in sepsis.
• To offer guidance on alternative induction agents and appropriate etomidate use.

Main Methods:

• Literature review of studies on etomidate's effects.
• Analysis of clinical data regarding hemodynamic stability and adrenal function.
• Case-based discussion of etomidate use in critical care settings.

Main Results:

• Etomidate facilitates smooth intubation and maintains hemodynamic stability.
• A single dose can lead to significant, prolonged adrenal insufficiency.
• The impact of this adrenal suppression in septic patients remains debated.

Conclusions:

• The use of etomidate in hemodynamically unstable patients requires careful consideration of risks and benefits.
• Adrenal insufficiency is a significant concern, particularly in septic patients.
• Alternative induction agents or judicious use of etomidate may be warranted.